Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Return on Investments of -56.97% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.00M |
|
-- |
|
-- |
|
$5.13M |
|
$-5.13M |
|
$0.13M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.13M |
|
$-5.11M |
|
2.83M |
|
2.83M |
|
$-1.77 |
|
$-1.77 |
|
| Balance Sheet Financials | |
$15.33M |
|
-- |
|
$0.36M |
|
$15.69M |
|
$5.35M |
|
-- |
|
$1.57M |
|
$6.92M |
|
$8.77M |
|
$8.41M |
|
$8.77M |
|
1.96M |
|
| Cash Flow Statement Financials | |
$-4.87M |
|
$4.12M |
|
$0.06M |
|
$3.82M |
|
$3.12M |
|
$-0.69M |
|
$0.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-56.97% |
|
-59.39% |
|
-31.85% |
|
|
Return on Investments |
-56.97% |
$4.47 |
|
$-1.72 |
|
$-1.72 |
|